Today is Saturday
Alerts and Headlines
Alerts
Seeking Alpha’s Quant Rating on SeaStar Medical Holding Corporation
SRPT
Losers: Sarepta Therapeutics (SRPT) -43% announces topline results from EMBARK, a global pivotal study of ELEVIDYS gene therapy for Duchenne muscular dystrophy.
![SRPT SRPT](https://ai.earningsahead.com/api/chart_rect/srpt.png)
Sputtering WM Motor Hopes For Recharge From New U.S. Listing With Kaixin - Part 2
SeaStar Medical gets FDA breakthrough status for cytokine storm device
Headlines
Why unsold new homes in the US South just hit a record high
New housing shortages are a problem across the US. But not in the South, and especially not in Florida and Texas.
Stock Market News, July 26, 2024: Dow Rallies 650 Points as Earnings Flurry Boosts Indexes
Read Finance on The Wall Street Journal
Stocks soar, Dow closes 650 points higher buoyed by bullish inflation report
The three major averages climbed on Friday.